Jonestrading restated their hold rating on shares of Deciphera Pharmaceuticals (NASDAQ:DCPH – Free Report) in a research note issued to investors on Monday morning, Benzinga reports. Jonestrading currently has a $25.60 price objective on the stock. Several other research firms also recently weighed in on DCPH. JPMorgan Chase & Co. lifted their target price on […]